Life Threatening Diseases
3 clinical trials · Condition
◉ Watch Life Threatening Diseases
| Record | Firm | Date |
|---|---|---|
| The Extreme Significance of Bilateral Embolic Retinal Phenomena That Can be Life Saving (NCT03078387) | Dr. Shawkat Michel | 2006-08-31 |
| Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases (NCT00154388) | Novartis Pharmaceuticals | 2001-02-01 |
Track Life Threatening Diseases automatically
Every clearance here is in the API, with alerts when new ones post.